Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Science Diction: The Origin Of The Word 'Cancer'

October 22, 2010 10:33 am | Podcasts | Comments

Around 400 B.C., Hippocrates is said to have named masses of cancerous cells karkinos -- Greek for crab. Science and medical historian Howard Markel discusses a few hypotheses on why Hippocrates named the disease after a crab, and how well cancer was understood in the ancient world.

Puzzling Over A Man And His Cube

October 22, 2010 10:33 am | Podcasts | Comments

Professor Erno Rubik's iconic puzzle, a simple, yet complex multicolored cube, took the world by storm in the 1980s and sold millions of copies. The inventor will receive a Lifetime Science Education Achievement Award from the USA Science & Engineering Festival this weekend.

Boston biotech finance head Baia dies

October 22, 2010 10:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Anne Baia, financial advisor and interim chief financial offier for several venture-backed Boston-area life sciences companies, died on Oct. 20 from cancer. She was 54 years old.

Advertisement

Europe approves expanded use of Boston Scientific stent

October 22, 2010 10:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Boston Scientific Corp. has received CE approval in Europe for expanded use of its WallFlex Biliary RX Fully Covered Stent for the treatment of benign bile duct strictures.

Fentanyl Transdermal System: Recall - Potential for Active Ingredient to Release Faster Than Specified

October 22, 2010 10:33 am | by U.S. Food & Drug Administration | News | Comments

Accelerated release of Fentanyl can lead to adverse events for at-risk patients, including excessive sedation, respiratory depression, hypoventilation, and apnea.

Lotus Pharmaceuticals Preparing to Apply for National Exchange Listing

October 22, 2010 9:33 am | by Bio-Medicine.Org | News | Comments

BEIJING, Oct. 22 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS ) ("Lotus" or the "Company"), a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), announced today that the...

TOPICS:

Bacterin International Holdings, Inc. Schedules Conference Call to Present Third Quarter 2010 Financial Results

October 22, 2010 9:33 am | by Bio-Medicine.Org | News | Comments

BELGRADE, Mont., Oct. 22 /- Bacterin International Holdings, Inc. (OTC Bulletin Board: BIHI ) ("Bacterin"), announced today that it has scheduled a conference call for Monday, November 15, 2010 at 10:00 a.m. (ET) to discuss the Company's financial results for its third quarter 2010, which...

TOPICS:

AdvaMed 2010 Sets New Attendance Record: More than 1,700 Device and Diagnostics Leaders from Across the Country and Around the World Came to Washington, D.C.

October 22, 2010 9:33 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Oct. 22 /PRNewswire-USNewswire/ -- More than 1,700 medical device and diagnostics leaders from more than 360 companies – representing 24 countries and 33 states – attended the fourth annual industry gathering, AdvaMed 2010: The MedTech Conference this week in...

TOPICS:
Advertisement

10 Tips for Breast Cancer Survivors

October 22, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

SEATTLE, Oct. 22 /- Throughout October, National Breast Cancer Awareness Month, experts from Fred Hutchinson Cancer Research Center and its clinical care partner, the Seattle Cancer Care Alliance, are offering weekly research-based tip sheets regarding breast cancer prevention, screening...

TOPICS:

Studies: Pneumonia is misdiagnosed on patient readmissions

October 22, 2010 9:32 am | by EurekAlert | News | Comments

(Henry Ford Health System) Patients were misdiagnosed with pneumonia at an alarming rate when they were readmitted to the hospital shortly after a previous hospitalization for the same illness, according to two Henry Ford Hospital companion studies.

TOPICS:

Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results

October 22, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

BALTIMORE, Oct. 22 /- Pharmaceutical company Pharmaxis (ASX: PXS) today announced significant results of pooled data from its two large scale six month Phase III trials of Bronchitol (inhaled mannitol) in people with cystic fibrosis. The combined results have been presented for the first...

TOPICS:

Boston Scientific Announces CE Mark Approval for Expanded Indication of WallFlex® Biliary RX Stent

October 22, 2010 8:31 am | by Bio-Medicine.Org | News | Comments

NATICK, Mass., Oct. 22 /- Boston Scientific Corporation (NYSE: BSX ) today announced that its WallFlex® Biliary RX Fully Covered Stent has received CE Mark approval for the treatment of benign biliary strictures.   "The WallFlex Biliary RX Fully Covered Stent has proved...

TOPICS:

GE Healthcare to Acquire Cancer Diagnostic Company Clarient Inc.

October 22, 2010 8:31 am | by Bio-Medicine.Org | News | Comments

CHALFONT ST GILES, UK and ALISO VIEJO, Calif., Oct. 22 /- GE Healthcare, a unit of General Electric Company (NYSE: GE ), and Clarient, Inc. (Nasdaq: CLRT ) announced today that they have entered into a definitive agreement for GE Healthcare to acquire Clarient, a leading player in the...

TOPICS:

Summary Box: GE to buy diagnostics firm Clarient

October 22, 2010 7:45 am | by The Associated Press | News | Comments

THE DEAL: General Electric Co. said its healthcare unit will buy diagnostics company Clarient Inc. to speed its expansion into cancer diagnostic and therapy selection tools.THE PARTICULARS: GE will start a cash tender offer of $5 per share for Clarient common stock and $20 for each preferred share....

Scorpion has welcome sting for heart bypass patients

October 22, 2010 7:34 am | by EurekAlert | News | Comments

(University of Leeds) A toxin found in the venom of the Central American bark scorpion (Centruroides margaritatus) could hold the key to reducing heart bypass failures, according to research from the University of Leeds.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading